1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends

Epiomic Epidemiology Series: Age-Related Macular Degeneration Forecast in 7 Major Markets 2016-2026

  • November 2015
  • 40 pages
  • Black Swan Analysis Ltd
Report ID: 3791850

Summary

Table of Contents

Search Inside

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Age-related Macular Degeneration (AMD) Disease in 7 Major Markets

Age-related macular degeneration (AMD or ARMD) or Age-related Maculopathy (ARM) is a condition that involves the degeneration and damage to the central area of the retina – the macula. It is currently a common cause of visual impairment in Western Europe. AMD is typically painless, and the loss of central vision usually occurs in both eyes but may progress at different speeds.
This report provides the current prevalent population for AMD across 7 Major Markets (USA, France, Germany, Italy, Spain, UK and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of AMD have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for AMD include:

• Serous retinal detachment
• Haemorrhage
• Charles Bonnet Syndrome
• Depression
• Reduced quality of life
• Hypertension
• Hypercholesterolaemia (abdominal obesity is a specific risk factor for males)

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

• Able to quantify patient populations in global AMD’s market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the prevalence of the subdivided types of AMD and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Provide a level of understanding on the impact from specific co-morbid conditions on AMD’s prevalent population.
• Identify sub-populations within AMD which require treatment.
• Gain an understanding of the specific markets that have the largest number of AMD patients.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Global Retinal Drugs Market 2017-2021

  • $ 3500
  • Industry report
  • July 2017
  • by Infiniti Research Limited

About Retinal Drugs Ophthalmic disorders largely consist of minor disorders that need minimal or no treatment, however, few other disorders become critical in nature and need specialist care. A delay in ...

High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein or Tropomyosin Related Kinase A or Tyrosine Kinase Receptor or gp140trk or p140 TrkA or NTRK1 or EC 2.7.10.1) - Pipeline

  • $ 3500
  • Industry report
  • June 2017
  • by Global Markets Direct

High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein or Tropomyosin Related Kinase A or Tyrosine Kinase Receptor or gp140trk ...

Global Gene Therapy Partnering Terms and Agreements 2010 to 2017

  • $ 2995
  • Industry report
  • April 2017
  • by Currentpartnering

Summary The Global Gene Therapy Partnering Terms and Agreements 2010-2017 report provides comprehensive understanding and unprecedented access to the gene therapy partnering deals and agreements entered ...


Download Unlimited Documents from Trusted Public Sources

Healthcare Industry in the UK

  • July 2017
    14 pages
  • Hospital  

  • United Kingdom  

    Europe  

View report >

Diabetes Statistics in the UK - Forecast

  • July 2017
    10 pages
  • Diabetes  

    Clinic  

  • United Kingdom  

View report >

Diabetes Statistics in the UK

  • July 2017
    48 pages
  • Diabetes  

    Cardiology  

    Hospital  

  • United Kingdom  

View report >

Related Market Segments :

Eye Disease
Ophthalmology
Epidemiology

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.